Cargando…

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

Methotrexate (MTX) is an important component in the therapy used to treat childhood acute lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme for MTX pharmacokinetics. Two single-nucleotide polymorphisms in MTHFR gene, C677T and A1298C, affecting MTHFR activity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umerez, Maitane, Gutierrez-Camino, Ángela, Muñoz-Maldonado, Carmen, Martin-Guerrero, Idoia, Garcia-Orad, Africa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376125/ https://www.ncbi.nlm.nih.gov/pubmed/28392709 http://dx.doi.org/10.2147/PGPM.S107047

Ejemplares similares

Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
por: Gutierrez-Camino, Angela, et al.
Publicado: (2018)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen, Yaqing, et al.
Publicado: (2021)

Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population
por: Gutierrez-Camino, Angela, et al.
Publicado: (2017)

Genetic Variants in MiRNA Processing Genes and Pre-MiRNAs Are Associated with the Risk of Chronic Lymphocytic Leukemia
por: Martin-Guerrero, Idoia, et al.
Publicado: (2015)

Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia
por: López-López, Elixabet, et al.
Publicado: (2014)

Rs4846049 Polymorphism at the 3′-UTR of MTHFR Gene: Association with Susceptibility to Childhood Acute Lymphoblastic Leukemia
por: Li, Xiaolei, et al.
Publicado: (2019)

Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population
por: Martin-Guerrero, Idoia, et al.
Publicado: (2018)

Association between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukemia in an Iranian Population
por: Bahari, Gholamreza, et al.
Publicado: (2016)

High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia
por: Jastaniah, Wasil, et al.
Publicado: (2018)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia
por: Cerezo, María, et al.
Publicado: (2009)

MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
por: Abedi, Marjan, et al.
Publicado: (2020)

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population
por: Schnakenberg, Eckart, et al.
Publicado: (2005)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

G9a Correlates with VLA-4 Integrin and Influences the Migration of Childhood Acute Lymphoblastic Leukemia Cells
por: Madrazo, Elena, et al.
Publicado: (2018)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
por: Zhang, Qian, et al.
Publicado: (2023)

Association of MTHFR Polymorphisms and Chromosomal Abnormalities in Leukemia
por: Sinthuwiwat, Thivaratana, et al.
Publicado: (2012)

Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014)

Association of ABCC2 −24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
por: Liu, Yan, et al.
Publicado: (2014)

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
por: Hao, Qishan, et al.
Publicado: (2022)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
por: Xu, Meng, et al.
Publicado: (2022)

MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate
por: Zhang, Qi, et al.
Publicado: (2022)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
por: Zhu, Jie, et al.
Publicado: (2022)

Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies
por: Han, Jian, et al.
Publicado: (2021)

Correction: Association of ABCC2 -24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
Publicado: (2014)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
por: Cwiklinska, Magdalena, et al.
Publicado: (2020)

Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia
por: Esmaili, Mohammad Ali, et al.
Publicado: (2020)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
por: Gervasini, Guillermo, et al.
Publicado: (2012)

Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
por: Pederzolli, Matteo, et al.
Publicado: (2022)

Methotrexate-Mediated Arachnoiditis in a Child with Acute Lymphoblastic Leukemia
por: Karamercan, Sırma, et al.
Publicado: (2022)

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report
por: Maya Naranjo, Maria Isabel, et al.
Publicado: (2023)

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2020)

More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate
por: Xie, Lu, et al.
Publicado: (2017)

Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population
por: Li, Xiaolei, et al.
Publicado: (2014)

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
por: Pearson, A. D., et al.
Publicado: (1991)

Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia
por: Yazıcıoğlu, Burcu, et al.
Publicado: (2017)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
por: Zhan, Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m1j6f05o90n8dvs8k73lllhfkn